Modelling Tau Distribution From DTI With Generative Adversarial Network for Alzheimer's Disease Diagnosis

Recruiting Observational Study
Alzheimer's Disease Diagnosis
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
55 and older
Sex
Any
Study type
Observational
Participants needed
250 (estimated)
Sponsor
Chinese University of Hong Kong · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The most significant impact of this project is to propose for the first time a novel generative adversarial network (GAN), as one kind of deep learning architecture, to automatically generate synthetic PET images reflecting tau deposition, from brain DTI images. If successful, this framework will become the most state-of-the-art approach to simulate the stereotypical pattern of intracerebral tau a…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * With the age of 55 years and above * With brain MRI taken within ±6 months from the date of clinically confirmed diagnosis of AD, MCI or normal cognition. Exclusion Criteria: * AD with mixed dementia * Non-AD dementia * History of severe traumatic brain injury, severe depres…
Contacts

No contact information available.